Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
781.67
+10.88 (1.41%)
At close: Feb 27, 2026, 4:00 PM EST
770.84
-10.83 (-1.39%)
After-hours: Feb 27, 2026, 7:19 PM EST

Regeneron Pharmaceuticals Employees

Regeneron Pharmaceuticals had 15,410 employees as of December 31, 2025. The number of employees increased by 304 or 2.01% compared to the previous year.

Employees
15,410
Change (1Y)
304
Growth (1Y)
2.01%
Revenue / Employee
$930,753
Profits / Employee
$292,336
Market Cap
80.21B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 202515,4103042.01%
Dec 31, 202415,1061,65612.31%
Dec 31, 202313,4501,59913.49%
Dec 31, 202211,8511,48314.30%
Dec 31, 202110,3681,24513.65%
Dec 31, 20209,1231,02312.63%
Dec 31, 20198,1007009.46%
Dec 31, 20187,4001,20019.35%
Dec 31, 20176,20080014.81%
Dec 31, 20165,4001,10025.58%
Dec 31, 20154,3001,37547.01%
Dec 31, 20142,92558525.00%
Dec 31, 20132,34039020.00%
Dec 31, 20121,95024614.44%
Dec 31, 20111,70430922.15%
Dec 31, 20101,39536635.57%
Dec 31, 20091,02911011.97%
Dec 31, 200891923734.75%
Dec 31, 200768210919.02%
Dec 31, 2006573-15-2.55%
Dec 31, 2005588-142-19.45%
Dec 31, 20047308613.35%
Dec 31, 2003644-25-3.74%
Dec 31, 20026699416.35%
Dec 31, 20015758417.11%
Dec 31, 20004915412.36%
Dec 31, 19994376617.79%
Dec 31, 199837110137.41%
Dec 31, 19972702711.11%
Dec 31, 1996243--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.